PBMCs Archives - Well Referenced

Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction

This 2022 randomized, double-blind, placebo-controlled trial evaluated the safety and tolerability of nicotinamide riboside (NR) in 30 patients with clinically stable heart failure with reduced ejection fraction (HFrEF). Participants received escalating doses of NR, reaching 1,000 mg twice daily over 12 weeks. The study found that NR was safe and

June 26, 2025 No Comments

Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function

This 1-month pilot clinical study evaluated the effects of daily oral supplementation with liposomal glutathione (500 mg or 1000 mg) in 12 healthy adults. Results showed significant increases in glutathione levels across various biological compartments, including whole blood (↑40%), erythrocytes (↑25%), plasma (↑28%), and PBMCs (↑100%) within two weeks (P

June 26, 2025 No Comments

Tag: PBMCs

Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction

Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function